|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman SL: Evolving challenges in
hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 7:425–436. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
White ES and Mantovani AR: Inflammation,
wound repair and fibrosis: Reassessing the spectrum of tissue
injury and resolution. J Pathol. 229:141–144. 2013. View Article : Google Scholar
|
|
5
|
Wynn TA and Ramalingam TR: Mechanisms of
fibrosis: Therapeutic translation for fibrotic disease. Nat Med.
18:1028–1040. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Osawa Y, Hannun YA, Proia RL and Brenner
DA: Roles of AKT and sphingosine kinase in the antiapoptotic
effects of bile duct ligation in mouse liver. Hepatology.
42:1320–1328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bourbonnais E, Raymond VA, Ethier C,
Nguyen BN, El-Leil MS, Meloche S and Bilodeau M: Liver fibrosis
protects mice from acute hepatocellular injury. Gastroenterology.
142:130–139.e4. 2012. View Article : Google Scholar
|
|
8
|
Javaherian K, Liu JF and Wang JC:
Nonhistone proteins HMG1 and HMG2 change the DNA helical structure.
Science. 199:1345–1346. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen R, Hou W, Zhang Q, Kang R, Fan XG and
Tang D: Emerging role of high-mobility group box 1 (HMGB1) in liver
diseases. Mol Med. 19:357–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li LC, Gao J and Li J: Emerging role of
HMGB1 in fibrotic diseases. J Cell Mol Med. 18:2331–2339. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Andersson U and Tracey KJ: HMGB1 is a
therapeutic target for sterile inflammation and infection. Annu Rev
Immunol. 29:139–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang H, Nace GW, McDonald KA, Tai S,
Klune JR, Rosborough BR, Ding Q, Loughran P, Zhu X, Beer-Stolz D,
et al: Hepatocyte-specific high-mobility group box 1 deletion
worsens the injury in liver ischemia/reperfusion: A role for
intracellular high-mobility group box 1 in cellular protection.
Hepatology. 59:1984–1997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kamo N, Ke B, Ghaffari AA, Shen XD,
Busuttil RW, Cheng G and Kupiec-Weglinski JW: ASC/caspase-1/IL-1β
signaling triggers inflammatory responses by promoting HMGB1
induction in liver ischemia/reperfusion injury. Hepatology.
58:351–362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sims GP, Rowe DC, Rietdijk ST, Herbst R
and Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev
Immunol. 28:367–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanai H, Ban T, Wang Z, Choi MK, Kawamura
T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, et al: HMGB
proteins function as universal sentinels for nucleic-acid-mediated
innate immune responses. Nature. 462:99–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Albayrak A, Uyanik MH, Cerrah S, Altas S,
Dursun H, Demir M and Uslu H: Is HMGB1 a new indirect marker for
revealing fibrosis in chronic hepatitis and a new therapeutic
target in treatment? Viral Immunol. 23:633–638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang FP, Li L, Li J, Wang JY, Wang LY and
Jiang W: High mobility group box-1 promotes the proliferation and
migration of hepatic stellate cells via TLR4-dependent signal
pathways of PI3K/Akt and JNK. PLoS One. 8:e643732013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong Q, Zhang H, Li JH, Duan LH, Zhong S,
Kong XL, Zheng F, Tan Z, Xiong P, Chen G, et al: High-mobility
group box 1 exacerbates concanavalin A-induced hepatic injury in
mice. J Mol Med (Berl). 88:1289–1298. 2010. View Article : Google Scholar
|
|
20
|
Zhou RR, Zhao SS, Zou MX, Zhang P, Zhang
BX, Dai XH, Li N, Liu HB, Wang H and Fan XG: HMGB1 cytoplasmic
translocation in patients with acute liver failure. BMC
Gastroenterol. 11(21)2011. View Article : Google Scholar
|
|
21
|
Kuroda N, Inoue K, Ikeda T, Hara Y, Wake K
and Sato T: Apoptotic response through a high mobility box 1
protein-dependent mechanism in LPS/GalN-induced mouse liver failure
and glycyrrhizin-mediated inhibition. PLoS One. 9:e928842014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Antoine DJ, Jenkins RE, Dear JW, Williams
DP, McGill MR, Sharpe MR, Craig DG, Simpson KJ, Jaeschke H and Park
BK: Molecular forms of HMGB1 and keratin-18 as mechanistic
biomarkers for mode of cell death and prognosis during clinical
acetaminophen hepatotoxicity. J Hepatol. 56:1070–1079. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsung A, Klune JR, Zhang X, Jeyabalan G,
Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR:
HMGB1 release induced by liver ischemia involves toll-like receptor
4 dependent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 204:2913–2923. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press; Washington (DC): 2011
|
|
25
|
Lefkowitch JH: Pathologic diagnosis of
liver disease. Hepatology - A Textbook of Liver Disease. Zakim D
and Boyer TD: W.B. Saunders Company; Philadelphia: pp. 844–871.
1996
|
|
26
|
Untergrasser A, Cutcutache I, Koressaar T,
Ye J, Faircloth BC, Remm M and Rozen SG: Primer 3 - new
capabilities and interfaces. Nucleic Acids Res. 40:e1152012.
View Article : Google Scholar
|
|
27
|
Dechêne A, Sowa JP, Gieseler RK, Jochum C,
Bechmann LP, El Fouly A, Schlattjan M, Saner F, Baba HA, Paul A, et
al: Acute liver failure is associated with elevated liver stiffness
and hepatic stellate cell activation. Hepatology. 52:1008–1016.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He Y, Jin L, Wang J, Yan Z, Chen T and
Zhao Y: Mechanisms of fibrosis in acute liver failure. Liver Int.
35:1877–1885. 2015. View Article : Google Scholar
|
|
29
|
Yang H, Hreggvidsdottir HS, Palmblad K,
Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y,
et al: A critical cysteine is required for HMGB1 binding to
Toll-like receptor 4 and activation of macrophage cytokine release.
Proc Natl Acad Sci USA. 107:11942–11947. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jung JH, Park JH, Jee MH, Keum SJ, Cho MS,
Yoon SK and Jang SK: Hepatitis C virus infection is blocked by
HMGB1 released from virus-infected cells. J Virol. 85:9359–9368.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Youn JH and Shin JS: Nucleocytoplasmic
shuttling of HMGB1 is regulated by phosphorylation that redirects
it toward secretion. J Immunol. 177:7889–7897. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonaldi T, Talamo F, Scaffidi P, Ferrera
D, Porto A, Bachi A, Rubartelli A, Agresti A and Bianchi ME:
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect
it towards secretion. EMBO J. 22:5551–5560. 2003. View Article : Google Scholar : PubMed/NCBI
|
